UZH-Logo

Maintenance Infos

Browse by Creators - Zurich Open Repository and Archive

Navigate back| Up a level
Export as
Number of items: 100.

Naegele, M; Flammer, A J; Enseleit, F; Roas, S; Frank, M; Hirt, A; Kaiser, P; Cantatore, S; Templin, C; Fröhlich, G; Romanens, M; Lüscher, T F; Ruschitzka, F; Noll, G; Sudano, I (2016). Endothelial function and sympathetic nervous system activity in patients with Takotsubo syndrome. International Journal of Cardiology, 224:226-230.

Rizzi, G; Startseva, X; Wolfrum, M; Lüscher, T F; Ruschitzka, F; Fröhlich, G M; Enseleit, F (2016). Unfavorable Donor Pretransplant APACHE II, SAPS II, and SOFA Scores Are Not Associated With Outcome: Implications for Heart Transplant Donor Selection. Transplantation Proceedings, 48(8):2582-2587.

Steffel, J; Rempel, H; Breitenstein, A; Schmidt, S; Namdar, M; Krasniqi, N; Holzmeister, J; Luscher, T F; Ruschitzka, F; Hurlimann, D (2014). Comprehensive cardiac resynchronization therapy (CRT) optimization in the real world. Cardiology Journal, 21(3):316-324.

Montalescot, G; Sechtem, U; Achenbach, S; Andreotti, F; Arden, C; Budaj, A; Bugiardini, R; Crea, F; Cuisset, T; Di Mario, C; Rafael Ferreira, J; Gersh, B J; Gitt, A K; Hulot, J S; Marx, N; Opie, L H; Pfisterer, M; Prescott, E; Ruschitzka, F; Sabate, M; Senior, R; Taggart, D P; van der Wall, E E; Vrints, C J (2014). Corrigendum to: '2013 ESC guidelines on the management of stable coronary artery disease'. European Heart Journal, 35(33):2260-2261.

Luscher, T F; Gersh, B; Landmesser, U; Ruschitzka, F (2014). Is the panic about beta-blockers in perioperative care justified? European Heart Journal, 35(36):2442-2444.

Kuck, K H; Bordachar, P; Borggrefe, M; Boriani, G; Burri, H; Leyva, F; Schauerte, P; Theuns, D; Thibault, B; Kirchhoff, P; Hasenfuss, G; Dickstein, K; Leclercq, C; Linde, C; Tavazzi, L; Ruschitzka, F (2014). New devices in heart failure: an European Heart Rhythm Association report: developed by the European Heart Rhythm Association; endorsed by the Heart Failure Association. Europace, 16(1):109-128.

Ghadri, J R; Ruschitzka, F; Lüscher, T F; Templin, C (2014). Prinzmetal angina. QJM : An International Journal of Medicine , 107(5):375-377.

Rauch, P J; Müllhaupt, B; Biedermann, L; Manz, M G; Ruschitzka, F; Flammer, A; Segerer, S T; Mohebbi, N; Jung, H H; Moch, H; Ikenberg, K; Aguzzi, A; Nuvolone, M; Distler, O; Rauch, A; Fehr, T H; Gerber, B (2014). Systemische Amyloidosen. Swiss Medical Forum, 14(50):943-948.

Ghadri, J R; Ruschitzka, F; Lüscher, T F; Templin, C (2014). Takotsubo cardiomyopathy: still much more to learn. Heart, 100(22):1804-1812.

Ertl, G; Ruschitzka, F (2014). The Year in Cardiology 2013: heart failure. European Heart Journal, 35(7):470-473.

Reser, D; Fröhlich, G M; Seifert, Burkhardt; Lachat, M L; Jacobs, S; Enseleit, F; Ruschitzka, F; Falk, V; Wilhelm, M J (2014). The impact of pretransplantation urgency status and the presence of a ventricular assist device on outcome after heart transplantation. Transplantation Proceedings, 46(5):1463-1468.

Montalescot, G; Sechtem, U; Achenbach, S; Andreotti, F; Arden, C; Budaj, A; Bugiardini, R; Crea, F; Cuisset, T; Di Mario, C; Ferreira, J R; Gersh, B J; Gitt, A K; Hulot, J S; Marx, N; Opie, L H; Pfisterer, M; Prescott, E; Ruschitzka, F; Sabaté, M; Senior, R; Taggart, D P; van der Wall, E E; Vrints, C J M; Zamorano, J L; Achenbach, S; Baumgartner, H; Bax, J J; Bueno, H; Dean, V; Deaton, C; Erol, C; Fagard, R; Ferrari, R; Hasdai, D; Hoes, A W; Kirchhof, P; Knuuti, J; Kolh, P; Lancellotti, P; Linhart, A; Nihoyannopoulos, P; Piepoli, M F; Ponikowski, P; Sirnes, P A; Tamargo, J L; Tendera, M; Torbicki, A; Wijns, W; Windecker, S; Knuuti, J; Valgimigli, M; Bueno, H; Claeys, M J; Donner-Banzhoff, N; Erol, C; Frank, H; Funck-Brentano, C; Gaemperli, O; Gonzalez-Juanatey, J R; Hamilos, M; Hasdai, D; Husted, S; James, S K; Kervinen, K; Kolh, P; Kristensen, S D; Lancellotti, P; Maggioni, A P; Piepoli, M F; Pries, A R; Romeo, F; Rydén, L; Simoons, M L; Sirnes, P A; Steg, P G; Timmis, A; Wijns, W; Windecker, S; Yildirir, A; Zamorano, J L (2013). 2013 ESC guidelines on the management of stable coronary artery disease: The Task Force on the management of stable coronary artery disease of the European Society of Cardiology. European Heart Journal, 34(38):2949-3003.

Ruschitzka, F; Abraham, W T; Singh, J P; Bax, J J; Borer, J S; Brugada, J; Dickstein, K; Ford, I; Gorcsan, J; Gras, D; Krum, H; Sogaard, P; Holzmeister, J (2013). Cardiac-resynchronization therapy in heart failure with a narrow QRS complex. New England Journal of Medicine, 369(15):1395-1405.

Wilhelm, M J; Ruschitzka, F; Falk, V (2013). Destination therapy - time for a paradigm change in heart failure therapy. Swiss Medical Weekly, 143:w13729.

Raess, M; Frohlich, G; Roos, Malgorzata; Rusi, B; Wilhelm, M J; Noll, G; Ruschitzka, F; Fehr, T; Enseleit, F (2013). Donor-specific anti-HLA antibodies detected by Luminex: predictive for short-term but not long-term survival after heart transplantation. Transplant International, 26(11):1097-1107.

Schaefer, N; Lohmann, C; Winnik, S; van Tits, L J; Miranda, M X; Vergopoulos, A; Ruschitzka, F; Nussberger, J; Berger, S; Luescher, T F; Verrey, F; Matter, C M (2013). Endothelial mineralocorticoid receptor activation mediates endothelial dysfunction in diet-induced obesity. European Heart Journal, 34(45):3515-3524.

Frohlich, G M; Keller, P; Schmid, F; Wolfrum, M; Osranek, M; Falk, C; Noll, G; Enseleit, F; Reinthaler, M; Meier, P; Luscher, T F; Ruschitzka, F; Tanner, F C (2013). Haemodynamically irrelevant pericardial effusion is associated with increased mortality in patients with chronic heart failure. European Heart Journal, 34(19):1414-1423.

Seferovic, P M; Stoerk, S; Filippatos, G; Mareev, V; Kavoliuniene, A; Ristic, A D; Ponikowski, P; McMurray, J; Maggioni, A; Ruschitzka, F; van Veldhuisen, D J; Coats, A; Piepoli, M; McDonagh, T; Riley, J; Hoes, A; Pieske, B; Dobric, M; Papp, Z; Mebazaa, A; Parissis, J; Ben Gal, T; Vinereanu, D; Brito, D; Altenberger, J; Gatzov, P; Milinkovic, I; Hradec, J; Trochu, J N; Amir, O; Moura, B; Lainscak, M; Comin, J; Wikstrom, G; Anker, S (2013). Organization of heart failure management in European Society of Cardiology member countries: survey of the Heart Failure Association of the European Society of Cardiology in collaboration with the Heart Failure National Societies/Working Groups. European Journal of Heart Failure, 15(9):947-959.

Winnik, S; Lohmann, C; Siciliani, G; von Lukowicz, T; Kuschnerus, K; Kraenkel, N; Brokopp, C E; Enseleit, F; Michels, S; Ruschitzka, F; Luscher, T F; Matter, C M (2013). Systemic VEGF inhibition accelerates experimental atherosclerosis and disrupts endothelial homeostasis - implications for cardiovascular safety. International Journal of Cardiology, 168(3):2453-2461.

Ruschitzka, F (2012). The challenge of nonresponders to cardiac resynchronization therapy: Lessons learned from oncology. Heart Rhythm, 9(8 Supp.):S14-S17.

Winnik, S; Raptis, D A; Walker, J H; Hasun, M; Speer, T; Clavien, P A; Komajda, M; Bax, J J; Tendera, M; Fox, K; Van de Werf, F; Mundow, C; Luscher, T F; Ruschitzka, F; Matter, C M (2012). From abstract to impact in cardiovascular research: factors predicting publication and citation. European Heart Journal, 33(24):3034-3045.

Ruschitzka, F; Taddei, S (2012). Angiotensin-converting enzyme inhibitors: first-line agents in cardiovascular protection? European Heart Journal, 33(16):1996-1998.

Flammer, A J; Sudano, I; Wolfrum, M; Thomas, R; Enseleit, F; Périat, D; Kaiser, P; Hirt, A; Hermann, M; Serafini, M; Lévêques, A; Lüscher, T F; Ruschitzka, F; Noll, G; Corti, R (2012). Cardiovascular effects of flavanol-rich chocolate in patients with heart failure. European Heart Journal, 33(17):2172-2180.

Sudano, I; Flammer, A J; Roas, S; Enseleit, F; Ruschitzka, F; Corti, R; Noll, G (2012). Cocoa, blood pressure, and vascular function. Current Hypertension Reports, 14(4):279-284.

Sudano, I; Roas, S; Flammer, A J; Noll, G; Ruschitzka, F (2012). Effekt von Paracetamol auf den Blutdruck bei Patienten mit koronarer Herzkrankheit. Praxis, 101(12):775-779.

Zbinden, A; Imhof, A; Wilhelm, M J; Ruschitzka, F; Wild, P; Bloemberg, G V; Mueller, N J (2012). Fatal outcome after heart transplantation caused by Aspergillus lentulus. Transplant Infectious Disease, 14(5):E60-E63.

Sudano, I; Flammer, A J; Roas, S; Enseleit, F; Noll, G; Ruschitzka, F (2012). Nonsteroidal antiinflammatory drugs, acetaminophen, and hypertension. Current Hypertension Reports, 14(4):304-309.

Flammer, A J; Ruschitzka, F (2012). Psoriasis and atherosclerosis: two plaques, one syndrome? European Heart Journal, 33(16):1989-1991.

Luscher, T F; Gersh, B; Hendricks, G; Landmesser, U; Ruschitzka, F; Wijns, W (2012). The best of the European Heart Journal: look back with pride. European Heart Journal, 33(10):1161-1171.

Simic, B; Hermann, M; Shaw, S G; Bigler, L; Stalder, U; Dörries, C; Besler, C; Lüscher, T F; Ruschitzka, F (2012). Torcetrapib impairs endothelial function in hypertension. European Heart Journal, 33(13):1615-1624.

Gheorghiade, M; Ruschitzka, F (2011). Beyond dyspnoea as an endpoint in acute heart failure trials. European Heart Journal, 32(12):1442-1445.

Steffel, J; Milosevic, G; Hürlimann, A; Krasniqi, N; Namdar, M; Ruschitzka, F; Lüscher, T F; Duru, F; Holzmeister, J; Hürlimann, D (2011). Characteristics and long-term outcome of echocardiographic super-responders to cardiac resynchronisation therapy: 'real world' experience from a single tertiary care centre. Heart, 97(20):1668-1674.

Hermann, M; Enseleit, F; Fisler, A E; Flammer, A; Lüscher, T F; Noll, G; Ruschitzka, F (2011). Cyclosporine C0- versus C2-monitoring over three years in maintenance heart transplantation. Swiss Medical Weekly, 141:w13149.

Ruschitzka, F; Abraham, W T (2011). Heart failure: In search of improved therapies for acute heart failure. Nature Reviews. Cardiology, 8(1):9-10.

Enseleit, F; Ruschitzka, F (2011). Is there a link between angiotensin receptor blockers and cancer? Current Hypertension Reports, 13(1):5-7.

Stähli, B E; Ruschitzka, F; Enseleit, F (2011). Isolated right ventricular ballooning syndrome: a new variant of transient cardiomyopathy. European Heart Journal, 32(14):1821.

Frey, S; Prêtre, René; Stiasny, B; Noll, G; Ruschitzka, F; Balmer, C (2011). Morbidity and mortality in children and adolescents listed for heart transplantation. Cardiovascular Medicine, 14(6):176-181.

Toggweiler, S; Borst, O; Enseleit, F; Hermann, M; Ruschitzka, F; Lüscher, T F; Noll, G (2011). NT-proBNP provides incremental prognostic information in cardiac outpatients with and without echocardiographic findings. Clinical Cardiology, 34(3):183-188.

Emmert, M Y; Prêtre, René; Ruschitzka, F; Krähenmann, F; Falk, V; Wilhelm, M J (2011). Peripartum cardiomyopathy with cardiogenic shock: recovery after prolactin inhibition and mechanical support. Annals of Thoracic Surgery, 91(1):274-276.

van Bommel, R J; Tanaka, H; Delgado, V; Bertini, M; Borleffs, C J W; Marsan, N A; Holzmeister, J; Ruschitzka, F; Schalij, M J; Bax, J J; Gorcsan, J (2010). Association of intraventricular mechanical dyssynchrony with response to cardiac resynchronization therapy in heart failure patients with a narrow QRS complex. European Heart Journal, 31(24):3054-3062.

Hürlimann, D; Steffel, J; Krasniqi, N; Milosevic, G; Gruner, C; Oswald, F; Rahn, M; Falk, V; Noll, G; Lüscher, T F; Ruschitzka, F; Holzmeister, J (2010). Kardiale Resynchronisationstherapie: "Real World"-Erfahrungen eines tertiären Zentrum in der Schweiz. Cardiovascular Medicine, 13(11):334-341.

Sudano, I; Flammer, A J; Périat, D; Enseleit, F; Hermann, M; Wolfrum, M; Hirt, A; Kaiser, P; Hurlimann, D; Neidhart, M; Gay, S; Holzmeister, J; Nussberger, J; Mocharla, P; Landmesser, U; Haile, S R; Corti, R; Vanhoutte, P M; Lüscher, T F; Noll, G; Ruschitzka, F (2010). Acetaminophen increases blood pressure in patients with coronary artery disease. Circulation, 122(18):1789-1796.

Enseleit, F; Michels, S; Ruschitzka, F (2010). Anti-VEGF therapies and blood pressure: more than meets the eye. Current Hypertension Reports, 12(1):33-38.

Enseleit, F; Ruschitzka, F (2010). Darusentan in resistant hypertension: lost in translation. Current Hypertension Reports, 12(1):1-3.

Enseleit, F; Lüscher, T F; Ruschitzka, F (2010). Darusentan, a selective endothelin A receptor antagonist, for the oral treatment of resistant hypertension. Therapeutic Advances in Cardiovascular Disease, 4(4):231-240.

Enseleit, F; Ruschitzka, F; Noll, G (2010). Diagnostik und medikamentöse Therapie der Herzinsuffizienz: Der Hausarzt stellt wichtige Weichen. Hausarzt Praxis, 5:7-9.

Lüscher, T F; Brugada, J; Gersh, B J; Landmesser, U; Serruys, P W; Murphy, S; Dedecke, S; Rogers, S; Ruschitzka, F (2010). Happy birthday European Heart Journal: in 30 years, from Cinderella to centre stage. European Heart Journal, 31(16):1945-1950.

Lüscher, T F; Landmesser, U; Ruschitzka, F (2010). Standing firm - the European Heart Journal, scientific controversies and the industry. European Heart Journal, 31(10):1157-1158.

Fröhlich, G; Steffel, J; Hürlimann, D; Enseleit, F; Lüscher, T F; Ruschitzka, F; Abraham, W T; Holzmeister, J (2010). Upgrading to resynchronization therapy after chronic right ventricular pacing improves left ventricular remodelling. European Heart Journal, 31(12):1477-1485.

Becker, M C; Wang, T H; Wisniewski, L; Wolski, K; Libby, P; Lüscher, T F; Borer, J S; Mascette, A M; Husni, M E; Solomon, D H; Graham, D Y; Yeomans, N D; Krum, H; Ruschitzka, F; Lincoff, A M; Nissen, S E (2009). Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis. American Heart Journal, 157(4):606-612.

Holzmeister, J; Hürlimann, D; Steffel, J; Ruschitzka, F (2009). Cardiac resynchronization therapy in patients with a narrow QRS. Current Heart Failure Reports, 6(1):49-56.

Flammer, A J; Vo, N T T; Ledergerber, B; Hermann, F; Gämperli, A; Huttner, A; Evison, J; Baumgartner, I; Cavassini, M; Hayoz, D; Quitzau, K; Hersberger, M; Sudano, I; Ruschitzka, F; Lüscher, T F; Noll, G; Weber, R (2009). Effect of atazanavir versus other protease inhibitor-containing antiretroviral therapy on endothelial function in HIV-infected persons: randomized controlled trial. Heart, 95(5):385-390.

Enseleit, F; Ruschitzka, F (2009). The BEAUTIFUL study: is heart rate reduction a new therapeutic principle? Current Hypertension Reports, 11(1):45-47.

Hermann, M; Ruschitzka, F (2009). The hypertension peril: lessons from CETP inhibitors. Current Hypertension Reports, 11(1):76-80.

Hermann, F; Enseleit, F; Spieker, L; Periat, D; Sudano, I; Hermann, M; Corti, R; Noll, G; Ruschitzka, F; Luscher, T F (2009). Cholesterylestertransfer protein inhibition and endothelial function in type II hyperlipidemia. Thrombosis Research, 123(3):460-465.

Lüscher, T F; Gersch, B; Brugada, J; Landmesser, U; Ruschitzka, F; Serruys, P W (2009). The European Heart Journal goes global: the road ahead of the editorial team 2009-2011. European Heart Journal, 30(1):1-5.

Messerli, F H; Bangalore, S; Ruschitzka, F (2009). Angiotensin receptor blockers: baseline therapy in hypertension? European Heart Journal, 30(20):2427-2430.

Enseleit, F; Ruschitzka, F (2009). Current treatment of age-related macular degeneration, determining the cardiovascular risk. British Journal of Cardiology, 16(Supp 2):3-7.

Sudano, I; Flammer, A J; Hermann, F; Syburra, T; Kaiser, P; Hirt, A; Hermann, M; Corti, R; Ruschitzka, F; Zund, G; Noll, G (2008). Auricall: A new device for a non-invasive, wireless, continuous monitoring of oxygen saturation and heart rate in patients with heart failure. International Journal of Cardiology, 129(1):141-143.

Enseleit, F; Lüscher, T F; Ruschitzka, F (2008). Darusentan: a new perspective for treatment of resistant hypertension? Expert Opinion on Investigational Drugs, 17(8):1255-1263.

Hermann, M; Ruschitzka, F (2008). Vitamin D and hypertension. Current Hypertension Reports, 10(1):49-51.

Flammer, A J; Sudano, I; Hermann, F; Gay, S; Forster, A; Neidhart, M; Künzler, P; Enseleit, F; Périat, D; Hermann, M; Nussberger, J; Luscher, T F; Corti, R; Noll, G; Ruschitzka, F (2008). Angiotensin-converting enzyme inhibition improves vascular function in rheumatoid arthritis. Circulation, 117(17):2262-2269.

Periat, D; Sudano, I; Enseleit, F; Noll, G (2008). Betablocker. In: Enseleit, F; Ruschitzka, F. Koronare Herzerkrankung und Herzinfarkt - Aktuelle Studien zur Sekündärprävention( KHK und Herzinfarkt - Aktuelle Studien zur Sekundärprävention). Bremen: UNI-MED Verlag, 82-88.

Cosentino, F; Hürlimann, D; Delli Gatti, C; Chenevard, R; Blau, N; Alp, N J; Channon, K M; Eto, M; Lerch, P; Enseleit, F; Ruschitzka, F; Volpe, M; Lüscher, T F; Noll, G (2008). Chronic treatment with tetrahydrobiopterin reverses endothelial dysfunction and oxidative stress in hypercholesterolaemia. Heart, 94(4):487-492.

Enseleit, F; Mueller, N J; Duru, F; Lachat, M; Noll, G; Ruschitzka, F (2008). Teicoplanin-induced complete AV-block in a heart transplant recipient. Infection, 36(3):291-292.

Mancia, G; de Backer, G; Dominiczak, A; Cifkova, R; Fagard, R; Germano, G; Grassi, G; Heagerty, A M; Kjeldsen, S E; Laurent, S; Narkiewicz, K; Ruilope, L; Rynkiewicz, A; Schmieder, R E; Struijker Boudier, H A; Zanchetti, A; Vahanian, A; Camm, J; de Caterina, R; Dean, V; Dickstein, K; Filippatos, G; Funck-Brentano, C; Hellemans, I; Kristensen, S D; McGregor, K; Sechtem, U; Silber, S; Tendera, M; Widimsky, P; Zamorano, J L; Erdine, S; Kiowski, W; Agabiti-Rosei, E; Ambrosioni, E; Lindholm, L H; Manolis, A; Nilsson, P M; Redon, J; Struijker-Boudier, H A; Viigimaa, M; Adamopoulos, S; Bertomeu, V; Clement, D; Farsang, C; Gaita, D; Lip, G; Mallion, J M; Manolis, A J; O'Brien, E; Ponikowski, P; Ruschitzka, F; Tamargo, J; van Zwieten, P; Waeber, B; Williams, B (2007). 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). European Heart Journal, 28(12):1462-1536.

Hermann, M; Ruschitzka, F (2007). Cardiovascular risk of cyclooxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs. Annals of Medicine, 39(1):18-27.

Camici, G G; Stallmach, T; Hermann, M; Hassink, R; Doevendans, P; Grenacher, B; Hirschy, A; Vogel, J; Lüscher, T F; Ruschitzka, F; Gassmann, M (2007). Constitutively overexpressed erythropoietin reduces infarct size in a mouse model of permanent coronary artery ligation. Methods in Enzymology, 435:147-155.

Flammer, A J; Hermann, F; Sudano, I; Spieker, L; et al; Lüscher, T F; Ruschitzka, F; Noll, G; Corti, R (2007). Dark chocolate improves coronary vasomotion and reduces platelet reactivity. Circulation, 116(21):2376-2382.

Flammer, A J; Hermann, F; Wiesli, P; Schwegler, B; Chenevard, R; Hurlimann, D; Sudano, I; Gay, S; Neidhart, M; Riesen, W; Ruschitzka, F; Lüscher, T F; Noll, G; Lehmann, R (2007). Effect of losartan, compared with atenolol, on endothelial function and oxidative stress in patients with type 2 diabetes and hypertension. Journal of Hypertension, 25(4):785-791.

Mancia, G; de Backer, G; Dominiczak, A F; Cifkova, R; Fagard, R; Germano, G; Grassi, G; Heagerty, A M; Kjeldsen, S E; Laurent, S; Narkiewicz, K; Ruilope, L; Rynkiewicz, A; Schmieder, R E; Boudier, H A; Zanchetti, A; Vahanian, A; Camm, J; De Caterina, R; Dean, V; Dickstein, K; Filippatos, G; Funck-Brentano, C; Hellemans, I; Kristensen, S D; McGregor, K; Sechtem, U; Silber, S; Tendera, M; Widimsky, P; Zamorano, J L; Erdine, S; Kiowski, W; Agabiti-Rosei, E; Ambrosioni, E; Lindholm, L H; Manolis, A; Nilsson, P M; Redon, J; Viigimaa, M; Adamopoulos, S; Bertomeu, V; Clement, D; Farsang, C; Gaita, D; Lip, G; Mallion, J M; Manolis, A J; O'Brien, E; Ponikowski, P; Ruschitzka, F; Tamargo, J; van Zwieten, P; Waeber, B; Williams, B (2007). Guías de práctica clínica para el tratamiento de la hipertensión arterial 2007. Revista Espanola de Cardiologna, 60(9):968 e1-994.

Ruschitzka, F (2007). Painful lessons: COX-2 inhibitors, NSAIDs, and hypertension. Current Hypertension Reports, 9(1):41-44.

Spieker, L E; Flammer, A J; Amacker, N; Sudano, I; Badimon, J J; Ruschitzka, F; Luscher, T F; Noll, G; Corti, R (2006). C-reactive protein influences shear stress-dependent platelet adhesion in patients with familiar hypercholesterolemia and coronary artery disease undergoing LDL apheresis. Thrombosis and Haemostasis, 96(4):540-542.

Krum, H; Ruschitzka, F (2006). Class effect amongst cardiac drugs: term of convenience or pharmacological reality? International Journal of Clinical Practice, 60(1):2-5.

Hermann, M; Ruschitzka, F (2006). Coxibs, non-steroidal anti-inflammatory drugs and cardiovascular risk. Internal Medicine Journal, 36(5):308-319.

Steffel, J; Luscher, T F; Ruschitzka, F; Tanner, F C (2006). Cyclooxygenase-2 inhibition and coagulation. Journal of Cardiovascular Pharmacology, 47 Sup:S15-20.

Hermann, F; Spieker, L E; Ruschitzka, F; Sudano, I; Hermann, M; Binggeli, C; Lüscher, T F; Riesen, W; Noll, G; Corti, R (2006). Dark chocolate improves endothelial and platelet function. Heart, 92(1):119-120.

Steffel, J; Akhmedov, A; Fahndrich, C; Ruschitzka, F; Luscher, T F; Tanner, F C (2006). Differential effect of celecoxib on tissue factor expression in human endothelial and vascular smooth muscle cells. Biochemical and Biophysical Research Communications (BBRC), 349(2):597-603.

Enseleit, F; Wyss, C A; Duru, F; Noll, G; Ruschitzka, F (2006). Images in cardiovascular medicine. The blue man: amiodarone-induced skin discoloration. Circulation, 113(5):e63.

Hermann, M; Ruschitzka, F (2006). Novel anti-inflammatory drugs in hypertension. Nephrology, Dialysis, Transplantation, 21(4):859-864.

Chenevard, R; Béchir, M; Hürlimann, D; Ruschitzka, F; Turina, J; Lüscher, T F; Noll, G (2006). Persistent endothelial dysfunction in calcified aortic stenosis beyond valve replacement surgery. Heart, 92(12):1862-1863.

Ruschitzka, F (2005). Are selective cyclo-oxygenase 2 inhibitors safe after coronary artery bypass grafting surgery? Nature Reviews. Cardiology (Nature Clinical Practice Cardiovascular Medicine), 2(10):504-505.

Sudano, I; et al; Ruschitzka, F; Noll, G (2005). Cardiovascular effects of coffee: is it a risk factor? Progress in Cardiovascular Nursing, 20(2):65-69.

Steffel, J; Hermann, M; Greutert, H; Gay, S; Lüscher, T F; Ruschitzka, F; Tanner, F C (2005). Celecoxib decreases endothelial tissue factor expression through inhibition of c-Jun terminal NH2 kinase phosphorylation. Circulation, 111(13):1685-1689.

Sudano, I; Spieker, L; Binggeli, C; Ruschitzka, F; Lüscher, T F; Noll, G; Corti, R (2005). Coffee blunts mental stress-induced blood pressure increase in habitual but not in nonhabitual coffee drinkers. Hypertension, 46(3):521-526.

Hermann, F; Ruschitzka, F; Spieker, L; Sudano, I; Noll, G; Corti, R (2005). Das süße Geheimnis der dunklen Schokolade. Therapeutische Umschau, 62(9):635-637.

Hermann, M; Shaw, S; Kiss, E; Camici, G; Buhler, N; Chenevard, R; Lüscher, T F; Gröne, H J; Ruschitzka, F (2005). Selective COX-2 inhibitors and renal injury in salt-sensitive hypertension. Hypertension, 45(2):193-197.

Hermann, F; et al; Noll, G; Ruschitzka, F (2005). Simvastatin improves endothelial function in patients with rheumatoid arthritis. Journal of the American College of Cardiology, 45(3):461-464.

Hermann, M; Krum, H; Ruschitzka, F (2005). To the heart of the matter: coxibs, smoking, and cardiovascular risk. Circulation, 112(7):941-945.

Dorschner, L; Speich, R; Ruschitzka, F; Seebach, J D; Gallino, A (2004). Everolimus-induced drug fever after heart transplantation. Transplantation, 78(2):303-304.

Spieker, L E; Ruschitzka, F; Lüscher, T F; Noll, G (2004). HDL and inflammation in atherosclerosis. Current Drug Targets. Immune, Endocrine & Metabolic Disorders, 4(1):51-57.

Anand, I; McMurray, J; Cohn, J N; Konstam, M A; Notter, T; Quitzau, K; Ruschitzka, F; Lüscher, T F (2004). Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the EndothelinA Receptor Antagonist Trial in Heart Failure (EARTH): randomised, double-blind, placebo-controlled trial. Lancet, 364(9431):347-354.

Karadag, B; Spieker, L E; Schwitter, J; Ruschitzka, F; Lüscher, T F; Noll, G; Corti, R (2004). Lyme carditis: restitutio ad integrum documented by cardiac magnetic resonance imaging. Cardiology in Review, 12(4):185-187.

Hürlimann, D; Enseleit, F; Ruschitzka, F (2004). Rheumatoide Arthritis, Inflammation und Atherosklerose. Herz, 29(8):760-768.

Spieker, L E; Ruschitzka, F; Badimon, J J; Noll, G; Corti, R (2004). Shear stress-dependent platelet function after LDL cholesterol apheresis. Thrombosis Research, 113(6):395-398.

Ruschitzka, F; et al; Noll, G; Lüscher, T F; Hänseler, E (2003). Detection of a novel exon 4 low-density lipoprotein receptor gene deletion in a swiss family with severe familial hypercholesterolemia. Clinical Chemistry and Laboratory Medicine, 41(3):266-271.

Hermann, M; et al; Lüscher, T F; Ruschitzka, F (2003). Differential effects of selective cyclooxygenase-2 inhibitors on endothelial function in salt-induced hypertension. Circulation, 108(19):2308-2311.

Béchir, M; Binggeli, C; Corti, R; Chenevard, R; Spieker, L; Ruschitzka, F; Lüscher, T F; Noll, G (2003). Dysfunctional baroreflex regulation of sympathetic nerve activity in patients with vasovagal syncope. Circulation, 107(12):1620-1625.

Ruschitzka, F; et al; Lüscher, T F; Gassmann, M (2003). Erythropoietin-induced excessive erythrocytosis activates the tissue endothelin system in mice. FASEB Journal, 17(2):259-261.

Chenevard, R; et al; Lüscher, T F; Noll, G; Ruschitzka, F (2003). Selective COX-2 inhibition improves endothelial function in coronary artery disease. Circulation, 107(3):405-409.

This list was generated on Sun Jul 23 04:17:34 2017 CEST.